Recent news on Caspofungin

Safety and efficacy of a caspofungin-based combination therapy for ...  -  Apr 18, 2007
BMC Pediatrics,We analyzed retrospectively the safety and efficacy of caspofungin-based combination therapy for 40 children and adolescents, most of them were being

It's Not Too Late  -  Apr 20, 2007
Kommersant,In addition, the boy will need to be treated with caspofungin and voriconazole for the fungus, at a cost of 496600 rubles.

Data on telavancin and micafungin hold promise of new therapeutic ...  -  Apr 3, 2007
Healthcare Republic...micafungin was associated with efficacy comparable to established treatments, liposomal amphotericin B (L-AmB) and intravenous caspofungin,

Posaconazole successful in treating fluconazole- and itraconazole ...  -  Feb 15, 2007
Aidsmap,These results compare favourably to those shown in other studies for itraconazole (55% to 80%), voriconazole (83%), and caspofungin (64%).

News Category : PressRelease  Oct 11, 2006
...to ensure appropriate antifungal therapy for patients with Candidemia and reduce unnecessary use of broad-spectrum and expensive agents, such as caspofungin. ... -Earthtimes.org Research and Markets: Examine Financial Performance of Merck & Co ...  Oct 9, 2006
Cancidas (caspofungin acetate) is a water-soluble semi-synthetic agent derived from a fermentation product discovered at Merck's laboratories in Madrid. ... -Genetic Engineering News (press release), Medical Center Saves $130K in Antifungal Drug Costs with C. ...  Sep 19, 2006
According to the study, "the most pronounced effect of the PNA FISH test was on caspofungin usage in patients with candidemia due to C. albicans. ... -PR Newswire

Schering-Plough: new fungicide gets US approval  Sep 20, 2006
Merck's Cancidas (caspofungin), the first drug in this class, was launched in 2001 and now dominates the market for systemic antifungals, achieving US sales ... -Pharmaceutical Business Review



Fungal prosthetic mitral valve endocarditis caused by ...  May 9, 2006
...particularly as relates to combination antifungal therapy and the role of newer azoles, such as posaconazole; the echinocandins, such as caspofungin; or the ... - The Journal of Thoracic and Cardiovascular Surgery

Infectious Diseases of the Fetus and Newborn Infant  Apr 18, 2006
...fetalis. The chapter on candidiasis is a current and highly readable summary with one minor error in references regarding caspofungin. ... - Journal of American Medical Association (subscription)





Amphotericin B the First Antifungal Drug Approved by the US is ...  Mar 14, 2006
Overall, the antifungal therapeutic market has been stagnating since the introduction of caspofungin (Mercks Cancidas) and voriconazole (Pfizers Vfend), both ... - Genetic Engineering News

TWO APPROACHES TO TREATMENT OF COMPLICATED CANDIDA GLABRATA ...  Jan 25, 2006
...a complicated UTI due to C. glabrata. The organism was eradicated after treatment with caspofungin. The second patient, a 58-year ... - The Journal of Pharmacy Technology

Read the factors that are changing the Antifungals Market today ...  Jan 25, 2006
Overall, the antifungal therapeutic market has been stagnating since the introduction of caspofungin (Mercks Cancidas) and voriconazole (Pfizers Vfend), both ... - Business Wire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional